SCHEMBL20711342

SCHEMBL20711342

Nc1cc(F)ccc1/C=C/S(=O)(=O)NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ SLC28A1 O00337 1/20 0.55
▸ MAP3K7 O43318 1/20 0.55
▸ SLC28A2 O43868 1/20 0.55
▸ GAPDH P04406 1/20 0.55
▸ ADORA3 P0DMS8 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ ADORA2A P29274 1/20 0.55
▸ ADORA2B P29275 1/20 0.55
▸ ADORA1 P30542 1/20 0.55
▸ STAT6 P42226 1/20 0.55
▸ PI4KA P42356 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ PI4K2B Q8TCG2 1/20 0.55
▸ DOT1L Q8TEK3 1/20 0.55
▸ SLC29A1 Q99808 1/20 0.55
▸ PI4K2A Q9BTU6 1/20 0.55
▸ SLC28A3 Q9HAS3 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20711276 0.91 DPP4 (0.55) DPP4MEN1SLC28A1MAP3K7SLC28A2
SCHEMBL20711226 0.91 DOT1L (0.56) DOT1L
SCHEMBL20711221 0.89 DPP4 (0.56) DPP4
SCHEMBL20711215 0.89 DPP4 (0.58) DPP4MEN1SLC28A1MAP3K7SLC28A2
SCHEMBL20711328 0.88 NNMT (0.59) DPP4MEN1SLC28A1MAP3K7SLC28A2
SCHEMBL20711349 0.86 DPP4 (0.55) DPP4MEN1SLC28A1MAP3K7SLC28A2
SCHEMBL20711279 0.86 DPP4 (0.56) DPP4MEN1SLC28A1MAP3K7SLC28A2
SCHEMBL22837893 0.85 TRPM2 (0.58) DPP4MEN1SLC28A1MAP3K7SLC28A2
SCHEMBL22837892 0.85 TRPM2 (0.58) DPP4MEN1SLC28A1MAP3K7SLC28A2
SCHEMBL20711233 0.85 TRPM2 (0.58) DPP4MEN1SLC28A1MAP3K7SLC28A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10874686-B2 Anthranilyl-adenosinemonosulfamate analogs and uses thereof MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2020-12-29 — — US disclosed
US-20190038656-A1 ANTHRANILYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF Memorial Slooan-Kettering Cancer Center (US) 2019-02-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10874686-B2 Anthranilyl-adenosinemonosulfamate analogs and uses thereof ATIC, SLC35B2, ADORA1 DPP4 1072/4885MEN1 3552/4885SLC28A1 20/4885
US-20190038656-A1 ANTHRANILYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF ATIC, SLC35B2, ADORA1 DPP4 1072/4885MEN1 3552/4885SLC28A1 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback